acquire and commercialize novel products

Aytu BioPharma is a specialty pharmaceutical company focused on advancing innovative medicines for complex central nervous system (CNS) diseases, with a distinct focus on psychiatric conditions including major depressive disorder (MDD) and attention deficit/hyperactivity disorder (ADHD). It also has a legacy portfolio addressing allergies and fluoride deficiency, and delivers treatments through a patient support program called Aytu RxConnect.

Read more

patient support programs